TELA Bio Analysts Cut Their Forecasts After Q4 Results

TELA Bio Analysts Cut Their Forecasts After Q4 Results

TELA Bio, Inc. (NASDAQ:TELA) reported mixed results for the fourth quarter on Tuesday. The company posted quarterly losses of 17 cents per share which beat the analyst consensus estimate of losses of 18 cents per share. The company reported quarterly sales of $20.869...